P
Pulsenmore Ltd
TASE:PULS
Pulsenmore Ltd
TASE:PULS
Price:
1 313
ILS
-0.15%
Market Closed
Market Cap:
₪83.2m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
P
|
Pulsenmore Ltd
TASE:PULS
|
IL |
|
BRD Klee A/S
CSE:KLEE B
|
DK |
Multiples-Based Value
The Multiples-Based Value of one PULS stock under the Base Case scenario is 301.02 ILS. Compared to the current market price of 1 313 ILS, Pulsenmore Ltd is Overvalued by 77%.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
PULS
Multiples-Based Value
Base Case
301.02
ILS
Overvaluation 77%
P
Multiples Across Competitors
PULS Competitors Multiples
Pulsenmore Ltd Competitors
Pulsenmore Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| IL |
P
|
Pulsenmore Ltd
TASE:PULS
|
83.2m ILS | 8.9 | -1.9 | -0.5 | -0.5 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
176.8B USD | 4 | 27.1 | 15.5 | 21.4 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
160.8B USD | 16 | 56.3 | 42.6 | 52.4 | |
| US |
|
Stryker Corp
NYSE:SYK
|
127B USD | 5.1 | 39.1 | 20 | 24.2 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
110.9B USD | 3.1 | 24 | 13.3 | 19.4 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
91.7B USD | 4.6 | 31.7 | 18.8 | 25.2 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
46.9B USD | 7.7 | 43.7 | 24 | 26.3 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
40.5B EUR | 1.7 | 19.2 | 10.8 | 15.3 | |
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
45.8B USD | 10.6 | 43.3 | 30.7 | 33.9 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
44.1B USD | 2 | 25.1 | 10 | 16.8 | |
| US |
|
Resmed Inc
NYSE:RMD
|
32.9B USD | 6.1 | 22.2 | 15.6 | 17.3 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
